🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lourdes Chuliá‐Peris

Universitat de València

ORCID: 0000-0002-0355-8187

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma”.

Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

Cancer Science(2024)10.1111/cas.16141

N/A

0.269DataRank · unranked

5 citations

Natalia Díaz‐Valdivia, Marta Gabasa, Rafael Ikemori, Marselina Arshakyan, Patricia Fernández‐Nogueira +11 more

Endothelin-1–Mediated Drug Resistance in EGFR -Mutant Non-Small Cell Lung Carcinoma

Cancer Research(2020)10.1158/0008-5472.can-20-0141

N/A

0DataRank · unranked

19 citations

Stephen Ollosi, Salvador Aparisi, Jeffrey H. Becker, Alicia Aliena‐Valero, Marta Benet +21 more

Data from Endothelin-1–Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma

(2023)10.1158/0008-5472.c.6512434.v1

N/A

0DataRank · unranked

0 citations

Stephen Ollosi, Salvador Aparisi, Jeffrey H. Becker, Alicia Aliena‐Valero, Marta Benet +21 more

NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC

Cancer Letters(2025)10.1016/j.canlet.2025.218032

N/A

0DataRank · unranked

0 citations

Juan Carlos García‐Cañaveras, Marta-Leonor Rodríguez, J.H.R. Becker, A. López, Miguel Aupí +23 more